GlaxoSmithKline receives US approval for HIV drug
Shares in pharmaceutical company GlaxoSmithKline (GSK) ticked up 0.6% to £16.01 after announcing that its injectable HIV drug Apretude has been approved by the US medicines regulator.The drug was developed by global specialist HIV...
21 December 2021